Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Jiangsu Hengrui Medicine Co.    600276   CNE0000014W7

JIANGSU HENGRUI MEDICINE CO. (600276)
My previous session
Most popular
  Report  
End-of-day quote. End-of-day quote  - 01/16
57.47 CNY   +1.82%
2018JIANGSU HENGRUI MEDICINE CO LTD : annual earnings release
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
01/10/2019 01/11/2019 01/14/2019 01/15/2019 01/16/2019 Date
56.27(c) 55.95(c) 54.33(c) 56.44(c) 57.47 Last
16 280 266 13 116 499 11 180 550 16 121 003 17 737 355 Volume
+1.33% -0.57% -2.90% +3.88% +1.82% Change
More quotes
Financials (CNY)
Sales 2018 17 160 M
EBIT 2018 4 488 M
Net income 2018 3 966 M
Finance 2018 8 571 M
Yield 2018 0,20%
Sales 2019 21 785 M
EBIT 2019 5 821 M
Net income 2019 5 107 M
Finance 2019 11 758 M
Yield 2019 0,25%
P/E ratio 2018 49,67
P/E ratio 2019 38,38
EV / Sales2018 11,2x
EV / Sales2019 8,64x
Capitalization 200 B
More Financials
Company
Jiangsu Hengrui Medicine Co. specializes in the research, development, manufacture and marketing of pharmaceutical products. Net sales break down by product family as follows: - anti-tumor drugs (41.4%; No. 1 Chinese);- Anesthetic drugs (26%); - contrast agents (13.7%): used in medical imaging;... 
Sector
Pharmaceuticals
Calendar
02/16Earnings Release
More about the company
Surperformance© ratings of Jiangsu Hengrui Medicine C
Trading Rating : Investor Rating :
More Ratings
Latest news on JIANGSU HENGRUI MEDICINE C
2018JIANGSU HENGRUI MEDICINE : LSK BioPharma and Jiangsu Hengrui Medicine Announce G..
AQ
2018JIANGSU HENGRUI MEDICINE CO LTD : Ex-dividend day for final dividend
FA
2018JIANGSU HENGRUI MEDICINE CO LTD : BONUS ISSUE: 3 new shares for 10 existing shar..
FA
2018JIANGSU HENGRUI MEDICINE : Procurement Project for Automatic Labeler Machine for..
AQ
2018JIANGSU HENGRUI MEDICINE : Procurement Project for Automatic Labeler Machine for..
AQ
2018JIANGSU HENGRUI MEDICINE CO LTD : annual earnings release
2018JIANGSU HENGRUI MEDICINE : and Arcutis Announce a Development and Commercializat..
BU
2017JIANGSU HENGRUI MEDICINE CO., LTD : 20% Stock Dividend
FA
2017JIANGSU HENGRUI MEDICINE CO., LTD : Ex-dividend day for final dividend
FA
2016JIANGSU HENGRUI MEDICINE CO., LTD : Ex-dividend day for final dividend
FA
More news
Analyst Recommendations on JIANGSU HENGRUI MEDICINE C
More recommendations
Sector news : Pharmaceuticals - NEC
02:48aBAYER : Roundup Faces New Setback in France
DJ
01/15European nations weigh impact of Brexit on drug supplies
RE
01/15Drug companies greet 2019 with U.S. price hikes
RE
01/15French court cancels Monsanto weedkiller permit on safety grounds
RE
01/15BAYER : Faces New Setback for Roundup Weedkiller in France
DJ
More sector news : Pharmaceuticals - NEC
Chart JIANGSU HENGRUI MEDICINE CO.
Duration : Period :
Jiangsu Hengrui Medicine Co. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JIANGSU HENGRUI MEDICINE C
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 72,8  CNY
Spread / Average Target 34%
EPS Revisions
Managers
NameTitle
Yun Shu Zhou President & Director
Wei Dong Chairman-Supervisory Board
Piao Yang Sun Chairman
Song Zhou Chief Financial Officer
Xin Hua Jiang Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
JIANGSU HENGRUI MEDICINE CO.7.00%29 590
JOHNSON & JOHNSON-0.60%344 044
PFIZER-2.93%245 746
NOVARTIS3.55%221 313
ROCHE HOLDING LTD.5.59%220 097
MERCK AND COMPANY-2.50%190 790